Selective JAK1 Inhibitor Atinvicitinib Shows Promise for Treating Canine Allergic Dermatitis
A novel selective JAK1 inhibitor, atinvicitinib, demonstrates significant potential for managing allergic and atopic dermatitis in dogs through precise immunological ...

